Claudio Montuori

16PUBLICATIONS
61CO-AUTHORS
Characterisation of biological macromoleculesProteins and peptidesNanotoxicology, health and safetyMedical virologyPain
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 19, 2025
Influence of Multiple Prior Endoscopic Sinus Surgeries on Dupilumab Efficacy Including Smell Function in the DUPIREAL Population.

Eugenio De Corso, Claudio Montuori, Elena Cantone

|Aug 30, 2025
Two-Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage.

Eugenio De Corso, Claudio Montuori, Carlotta Pipolo

|Jul 28, 2025
Strategies for Tapering the Dosage of Biologics Targeting Type 2 Inflammation: A Systematic Review.

Antonella Loperfido, Claudio Montuori, Marco Caminati

|Mar 28, 2025
Dupilumab Monthly Dose De-Escalation Maintains Efficacy in CRSwNP: A Two-Year Real-World Study.

Eugenio De Corso, Claudio Montuori, Gabriele De Maio

|Jul 27, 2024
Dupilumab Improves Facial Pain and Reduces Rescue Treatments in Patients with CRSwNP and Recalcitrant Frontal Sinusitis.

Eugenio De Corso, Stefano Settimi, Daniele Penazzi

|May 07, 2024
Comparative real-world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patients.

Eugenio De Corso, Davide Paolo Porru, Marco Corbò

Pageof 3

Frequent Collaborators

16 joint publications

Eugenio De Corso

7 joint publications

Stefano Settimi

5 joint publications

Jacopo Galli

4 joint publications

Elena Cantone